What must a pharmacy do if a patient receives a generic medication instead of a brand?

A pharmacy must ensure that the patient is informed about receiving a generic medication instead of a brand-name medication and retains the right to refuse the substitution. This is an important part of patient autonomy and informed consent. Patients should have the opportunity to be involved in their medication choices and understand any implications of switching to a generic alternative.

In many states, regulations require that patients be notified when a substitution occurs, which supports their ability to make informed decisions about their health care. This practice helps foster trust between the patient and the pharmacist, as it emphasizes clear communication about the treatment being provided.

While other options may relate to cost, counseling, or refunds, they do not fundamentally capture the essential aspect of patient choice and informed consent required by law and ethical pharmacy practice. The focus is on ensuring that patients have the knowledge and autonomy to accept or decline the medication offered to them.